Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 28, 2017; 23(4): 723-729
Published online Jan 28, 2017. doi: 10.3748/wjg.v23.i4.723
Published online Jan 28, 2017. doi: 10.3748/wjg.v23.i4.723
Characteristic | Continuing group | Discontinuing group | T/χ2 | P value |
No. of patients | 98 | 69 | ||
Demographic data | ||||
Gender (male/%) | 68 (69.39) | 42 (60.87) | 1.307 | 0.253 |
Age (mean ± SD) | 70.8 ± 11.4 | 62.4 ± 12.0 | 4.588 | 0.000 |
BMI (kg/m2, mean ± SD) | 21.4 ± 4.5 | 22.0 ± 4.2 | 0.872 | 0.385 |
Complications | ||||
Smoking and alcohol abuse | 8 (8.2) | 15 (21.7) | 6.284 | 0.012 |
Diabetes | 32 (32.7) | 15 (21.7) | 2.385 | 0.123 |
Hypertension | 71 (72.4) | 56 (81.2) | 1.338 | 0.247 |
Chronic kidney disease | 23 (23.4) | 8 (11.6) | 3.777 | 0.052 |
Chronic obstructive pulmonary disease | 10 (10.2) | 8 (11.6) | 0.081 | 0.775 |
Acute cardiovascular disease | 65 (66.3) | 13 (18.8) | 36.681 | 0.000 |
Non-antithrombotic drug usage | ||||
Aspirin | 84 (85.7) | 59 (85.5) | 0.001 | 0.970 |
Forrest classification | ||||
I-II | 31 (31.6) | 28 (40.6) | 1.419 | 0.234 |
III | 67 (68.4) | 41 (59.4) | 1.419 | 0.234 |
Hemoglobin (g/dL) | 9.0 ± 2.4 | 8.6 ± 2.1 | 1.116 | 0.266 |
- Citation: Wang XX, Dong B, Hong B, Gong YQ, Wang W, Wang J, Zhou ZY, Jiang WJ. Long-term prognosis in patients continuing taking antithrombotics after peptic ulcer bleeding. World J Gastroenterol 2017; 23(4): 723-729
- URL: https://www.wjgnet.com/1007-9327/full/v23/i4/723.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i4.723